Ningbo Taikang Taxus Bioengineering

Ningbo Taikang Taxus Bioengineering is a specialized biotechnology company based in China that focuses on the production of taxane-based active pharmaceutical ingredients (APIs). The company manages extensive Taxus (yew tree) plantations to provide a sustainable source of raw materials for the extraction of Paclitaxel, 10-deacetylbaccatin III (10-DAB III), and other related compounds. Their core business involves the large-scale purification of these substances to meet international GMP standards for use in oncology treatments. By integrating agricultural cultivation with high-tech chemical processing, they serve as a key supplier to the global pharmaceutical industry for anti-cancer drug manufacturing. Their product portfolio includes Paclitaxel, Docetaxel, and Cabazitaxel, supporting therapies for various solid tumors.